Solodyn and Updates on Topical and Oral Therapies for Acne Whitney P. BoweJaimie B. GlickAlan R. Shalita Dermatopharmacology and Therapeutic Development (J Zeichner, Section Editor) 17 June 2012 Pages: 97 - 107
Psoriasis: Ustekinumab and Other Biologics in the Pipeline Noori KimAlice B. Gottlieb Dermatopharmacology and Therapeutic Development (J Zeichner, Section Editor) 05 July 2012 Pages: 108 - 114
Skin Barrier Repair in Eczema: A Review of Current Understanding of Pathophysiology and Treatment Omar PachaBrittany L. SambranoAdelaide A. Hebert Dermatopharmacology and Therapeutic Development (J Zeichner, Section Editor) 10 July 2012 Pages: 115 - 122
Skin Cancer Prevention: Recent Evidence from Randomized Controlled Trials Adèle C. GreenCatherine A. HarwoodH. Peter Soyer Clinical Trial Design and Outcome Measures (L Naldi, Section Editor) 05 July 2012 Pages: 123 - 130
Severity Assessment and Outcome Measures in Acne Vulgaris Kian ZarchiGregor B. E. Jemec Clinical Trial Design and Outcome Measures (L Naldi, Section Editor) 05 July 2012 Pages: 131 - 136
Outcomes in Psoriasis Clinical Trials from January 2011 to March 2012 Francesca SampognaDamiano Abeni Clinical Trial Design and Outcome Measures (L Naldi, Section Editor) 08 July 2012 Pages: 137 - 147
Quality of Life Measures for Dermatology: Definition, Evaluation, and Interpretation Matthias AugustinAnna K. LangenbruchChristine Blome Clinical Trial Design and Outcome Measures (L Naldi, Section Editor) 09 August 2012 Pages: 148 - 159